Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-22-000006

Director acquired 819 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GROGAN DONNA ROY Director 2022-10-03 Grant or award +819 $8.69 $7,117 819 D: show line 1 in the form
Loading xslF345X03/wf-form4_166492116846862.xml…